Biomaterials in percutaneous vertebroplasty
Aim. The purpose of this study is to reveal the safety and efficacy of biomaterials used in VPP in the treatment of vertebral spinal vertebral patients and primary vertebral tumors. Material and method. The retrospective study (December 2012-December 2015) included 21 patients admitted to the Sanado...
Ausführliche Beschreibung
Autor*in: |
Dan Răzvan BENTIA [verfasserIn] Gabriel IACOB [verfasserIn] Alexandru Vlad CIUREA [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2017 |
---|
Schlagwörter: |
---|
Übergeordnetes Werk: |
In: Romanian Journal of Medical Practice - Amaltea Medical Publishing House, 2019, 12(2017), 4, Seite 212-219 |
---|---|
Übergeordnetes Werk: |
volume:12 ; year:2017 ; number:4 ; pages:212-219 |
Links: |
Link aufrufen |
---|
DOI / URN: |
10.37897/RJMP.2017.4.7 |
---|
Katalog-ID: |
DOAJ061155349 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | DOAJ061155349 | ||
003 | DE-627 | ||
005 | 20230309010110.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230228s2017 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.37897/RJMP.2017.4.7 |2 doi | |
035 | |a (DE-627)DOAJ061155349 | ||
035 | |a (DE-599)DOAJf750f5d1257c4c2daaf53f394cbcdbbe | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
050 | 0 | |a R5-920 | |
100 | 0 | |a Dan Răzvan BENTIA |e verfasserin |4 aut | |
245 | 1 | 0 | |a Biomaterials in percutaneous vertebroplasty |
264 | 1 | |c 2017 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Aim. The purpose of this study is to reveal the safety and efficacy of biomaterials used in VPP in the treatment of vertebral spinal vertebral patients and primary vertebral tumors. Material and method. The retrospective study (December 2012-December 2015) included 21 patients admitted to the Sanador Hospitals Department of Neurosurgery and Clinical Orthopedics-Traumatology and Osteoarticular TBC "Foişor", Bucharest, with VPP indication. Patients were diagnosed with vertebral spindles produced by vertebral metastases and primary vertebral tumors without compression in the vertebral canal. The diagnosis of these vertebral compressions has been established and confirmed by medical history, medical history, paraclinical investigation studies: column and face colorectal radiographs, native and contrast vertebral CT, 3D bone reconstruction and reconstruction, and native vertebral MRI contrast. Results. All VPPs have been technically successful, being well tolerated by patients, improved spinal algal symptomatology, rapid postoperative resumption of patient mobility. There were no major postoperative complications such as material migration into the canal, pulmonary embolism with material, infections, postoperative local haematomas, local or systemic reactions to VertaPlex®. All 21 patients were relieved with improved general condition without major postoperative complications. Clinical follow-up data over a 12-month period, detailed at 1, 3, 6, and 12 months after VPP and assessed with visual analogue scale, the Oswestry Disability Score Index and the Karnofsky Performance Scale have demonstrated, along with technical success, a significantly reduced rate of clinical pain, an improvement in disability and a real increase in quality of life and mobility in patients selected for study. Discussions. PMMA still prevails in choosing as a biomaterial in VPP but is not intrinsically degradable, which is a major barrier to wider applications. In order to eliminate the drawbacks of classical VPPs, new bone cements with biodegradable CPC potential have been generated, with a lower toxic potential than PMMA, and which can be improved by bone-stimulation-enhancing elements. Conclusions. VPP actually increases the quality of life of patients with vertebral spine caused by vertebral metastases and primary vertebral tumors. Biodegradability and biocompatibility, minimal exothermic reactions and insignificant contraction imply that biodegradable and mechanically assembled bone cements without graft rejection will be the future of VPP biomaterials. | ||
650 | 4 | |a biomaterials | |
650 | 4 | |a vertebral fractures | |
650 | 4 | |a vertebral metastases | |
650 | 4 | |a vertebral tumors | |
650 | 4 | |a pmma | |
650 | 4 | |a percutaneous vertebroplasty | |
653 | 0 | |a Medicine | |
653 | 0 | |a R | |
653 | 0 | |a Medicine (General) | |
700 | 0 | |a Gabriel IACOB |e verfasserin |4 aut | |
700 | 0 | |a Alexandru Vlad CIUREA |e verfasserin |4 aut | |
773 | 0 | 8 | |i In |t Romanian Journal of Medical Practice |d Amaltea Medical Publishing House, 2019 |g 12(2017), 4, Seite 212-219 |w (DE-627)634381776 |w (DE-600)2570962-8 |x 20696108 |7 nnns |
773 | 1 | 8 | |g volume:12 |g year:2017 |g number:4 |g pages:212-219 |
856 | 4 | 0 | |u https://doi.org/10.37897/RJMP.2017.4.7 |z kostenfrei |
856 | 4 | 0 | |u https://doaj.org/article/f750f5d1257c4c2daaf53f394cbcdbbe |z kostenfrei |
856 | 4 | 0 | |u https://rjmp.com.ro/articles/2017.4/RJMP_2017_4_Art-07.pdf |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/1842-8258 |y Journal toc |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/2069-6108 |y Journal toc |z kostenfrei |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_DOAJ | ||
912 | |a GBV_ILN_20 | ||
912 | |a GBV_ILN_22 | ||
912 | |a GBV_ILN_23 | ||
912 | |a GBV_ILN_24 | ||
912 | |a GBV_ILN_31 | ||
912 | |a GBV_ILN_39 | ||
912 | |a GBV_ILN_40 | ||
912 | |a GBV_ILN_60 | ||
912 | |a GBV_ILN_62 | ||
912 | |a GBV_ILN_63 | ||
912 | |a GBV_ILN_65 | ||
912 | |a GBV_ILN_69 | ||
912 | |a GBV_ILN_73 | ||
912 | |a GBV_ILN_74 | ||
912 | |a GBV_ILN_95 | ||
912 | |a GBV_ILN_105 | ||
912 | |a GBV_ILN_110 | ||
912 | |a GBV_ILN_151 | ||
912 | |a GBV_ILN_161 | ||
912 | |a GBV_ILN_170 | ||
912 | |a GBV_ILN_206 | ||
912 | |a GBV_ILN_213 | ||
912 | |a GBV_ILN_230 | ||
912 | |a GBV_ILN_285 | ||
912 | |a GBV_ILN_293 | ||
912 | |a GBV_ILN_602 | ||
912 | |a GBV_ILN_2005 | ||
912 | |a GBV_ILN_2009 | ||
912 | |a GBV_ILN_2011 | ||
912 | |a GBV_ILN_2014 | ||
912 | |a GBV_ILN_2055 | ||
912 | |a GBV_ILN_2111 | ||
912 | |a GBV_ILN_4012 | ||
912 | |a GBV_ILN_4037 | ||
912 | |a GBV_ILN_4112 | ||
912 | |a GBV_ILN_4125 | ||
912 | |a GBV_ILN_4126 | ||
912 | |a GBV_ILN_4249 | ||
912 | |a GBV_ILN_4305 | ||
912 | |a GBV_ILN_4306 | ||
912 | |a GBV_ILN_4307 | ||
912 | |a GBV_ILN_4313 | ||
912 | |a GBV_ILN_4322 | ||
912 | |a GBV_ILN_4323 | ||
912 | |a GBV_ILN_4324 | ||
912 | |a GBV_ILN_4325 | ||
912 | |a GBV_ILN_4338 | ||
912 | |a GBV_ILN_4367 | ||
912 | |a GBV_ILN_4700 | ||
951 | |a AR | ||
952 | |d 12 |j 2017 |e 4 |h 212-219 |
author_variant |
d r b drb g i gi a v c avc |
---|---|
matchkey_str |
article:20696108:2017----::imtrasnectnoset |
hierarchy_sort_str |
2017 |
callnumber-subject-code |
R |
publishDate |
2017 |
allfields |
10.37897/RJMP.2017.4.7 doi (DE-627)DOAJ061155349 (DE-599)DOAJf750f5d1257c4c2daaf53f394cbcdbbe DE-627 ger DE-627 rakwb eng R5-920 Dan Răzvan BENTIA verfasserin aut Biomaterials in percutaneous vertebroplasty 2017 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Aim. The purpose of this study is to reveal the safety and efficacy of biomaterials used in VPP in the treatment of vertebral spinal vertebral patients and primary vertebral tumors. Material and method. The retrospective study (December 2012-December 2015) included 21 patients admitted to the Sanador Hospitals Department of Neurosurgery and Clinical Orthopedics-Traumatology and Osteoarticular TBC "Foişor", Bucharest, with VPP indication. Patients were diagnosed with vertebral spindles produced by vertebral metastases and primary vertebral tumors without compression in the vertebral canal. The diagnosis of these vertebral compressions has been established and confirmed by medical history, medical history, paraclinical investigation studies: column and face colorectal radiographs, native and contrast vertebral CT, 3D bone reconstruction and reconstruction, and native vertebral MRI contrast. Results. All VPPs have been technically successful, being well tolerated by patients, improved spinal algal symptomatology, rapid postoperative resumption of patient mobility. There were no major postoperative complications such as material migration into the canal, pulmonary embolism with material, infections, postoperative local haematomas, local or systemic reactions to VertaPlex®. All 21 patients were relieved with improved general condition without major postoperative complications. Clinical follow-up data over a 12-month period, detailed at 1, 3, 6, and 12 months after VPP and assessed with visual analogue scale, the Oswestry Disability Score Index and the Karnofsky Performance Scale have demonstrated, along with technical success, a significantly reduced rate of clinical pain, an improvement in disability and a real increase in quality of life and mobility in patients selected for study. Discussions. PMMA still prevails in choosing as a biomaterial in VPP but is not intrinsically degradable, which is a major barrier to wider applications. In order to eliminate the drawbacks of classical VPPs, new bone cements with biodegradable CPC potential have been generated, with a lower toxic potential than PMMA, and which can be improved by bone-stimulation-enhancing elements. Conclusions. VPP actually increases the quality of life of patients with vertebral spine caused by vertebral metastases and primary vertebral tumors. Biodegradability and biocompatibility, minimal exothermic reactions and insignificant contraction imply that biodegradable and mechanically assembled bone cements without graft rejection will be the future of VPP biomaterials. biomaterials vertebral fractures vertebral metastases vertebral tumors pmma percutaneous vertebroplasty Medicine R Medicine (General) Gabriel IACOB verfasserin aut Alexandru Vlad CIUREA verfasserin aut In Romanian Journal of Medical Practice Amaltea Medical Publishing House, 2019 12(2017), 4, Seite 212-219 (DE-627)634381776 (DE-600)2570962-8 20696108 nnns volume:12 year:2017 number:4 pages:212-219 https://doi.org/10.37897/RJMP.2017.4.7 kostenfrei https://doaj.org/article/f750f5d1257c4c2daaf53f394cbcdbbe kostenfrei https://rjmp.com.ro/articles/2017.4/RJMP_2017_4_Art-07.pdf kostenfrei https://doaj.org/toc/1842-8258 Journal toc kostenfrei https://doaj.org/toc/2069-6108 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 12 2017 4 212-219 |
spelling |
10.37897/RJMP.2017.4.7 doi (DE-627)DOAJ061155349 (DE-599)DOAJf750f5d1257c4c2daaf53f394cbcdbbe DE-627 ger DE-627 rakwb eng R5-920 Dan Răzvan BENTIA verfasserin aut Biomaterials in percutaneous vertebroplasty 2017 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Aim. The purpose of this study is to reveal the safety and efficacy of biomaterials used in VPP in the treatment of vertebral spinal vertebral patients and primary vertebral tumors. Material and method. The retrospective study (December 2012-December 2015) included 21 patients admitted to the Sanador Hospitals Department of Neurosurgery and Clinical Orthopedics-Traumatology and Osteoarticular TBC "Foişor", Bucharest, with VPP indication. Patients were diagnosed with vertebral spindles produced by vertebral metastases and primary vertebral tumors without compression in the vertebral canal. The diagnosis of these vertebral compressions has been established and confirmed by medical history, medical history, paraclinical investigation studies: column and face colorectal radiographs, native and contrast vertebral CT, 3D bone reconstruction and reconstruction, and native vertebral MRI contrast. Results. All VPPs have been technically successful, being well tolerated by patients, improved spinal algal symptomatology, rapid postoperative resumption of patient mobility. There were no major postoperative complications such as material migration into the canal, pulmonary embolism with material, infections, postoperative local haematomas, local or systemic reactions to VertaPlex®. All 21 patients were relieved with improved general condition without major postoperative complications. Clinical follow-up data over a 12-month period, detailed at 1, 3, 6, and 12 months after VPP and assessed with visual analogue scale, the Oswestry Disability Score Index and the Karnofsky Performance Scale have demonstrated, along with technical success, a significantly reduced rate of clinical pain, an improvement in disability and a real increase in quality of life and mobility in patients selected for study. Discussions. PMMA still prevails in choosing as a biomaterial in VPP but is not intrinsically degradable, which is a major barrier to wider applications. In order to eliminate the drawbacks of classical VPPs, new bone cements with biodegradable CPC potential have been generated, with a lower toxic potential than PMMA, and which can be improved by bone-stimulation-enhancing elements. Conclusions. VPP actually increases the quality of life of patients with vertebral spine caused by vertebral metastases and primary vertebral tumors. Biodegradability and biocompatibility, minimal exothermic reactions and insignificant contraction imply that biodegradable and mechanically assembled bone cements without graft rejection will be the future of VPP biomaterials. biomaterials vertebral fractures vertebral metastases vertebral tumors pmma percutaneous vertebroplasty Medicine R Medicine (General) Gabriel IACOB verfasserin aut Alexandru Vlad CIUREA verfasserin aut In Romanian Journal of Medical Practice Amaltea Medical Publishing House, 2019 12(2017), 4, Seite 212-219 (DE-627)634381776 (DE-600)2570962-8 20696108 nnns volume:12 year:2017 number:4 pages:212-219 https://doi.org/10.37897/RJMP.2017.4.7 kostenfrei https://doaj.org/article/f750f5d1257c4c2daaf53f394cbcdbbe kostenfrei https://rjmp.com.ro/articles/2017.4/RJMP_2017_4_Art-07.pdf kostenfrei https://doaj.org/toc/1842-8258 Journal toc kostenfrei https://doaj.org/toc/2069-6108 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 12 2017 4 212-219 |
allfields_unstemmed |
10.37897/RJMP.2017.4.7 doi (DE-627)DOAJ061155349 (DE-599)DOAJf750f5d1257c4c2daaf53f394cbcdbbe DE-627 ger DE-627 rakwb eng R5-920 Dan Răzvan BENTIA verfasserin aut Biomaterials in percutaneous vertebroplasty 2017 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Aim. The purpose of this study is to reveal the safety and efficacy of biomaterials used in VPP in the treatment of vertebral spinal vertebral patients and primary vertebral tumors. Material and method. The retrospective study (December 2012-December 2015) included 21 patients admitted to the Sanador Hospitals Department of Neurosurgery and Clinical Orthopedics-Traumatology and Osteoarticular TBC "Foişor", Bucharest, with VPP indication. Patients were diagnosed with vertebral spindles produced by vertebral metastases and primary vertebral tumors without compression in the vertebral canal. The diagnosis of these vertebral compressions has been established and confirmed by medical history, medical history, paraclinical investigation studies: column and face colorectal radiographs, native and contrast vertebral CT, 3D bone reconstruction and reconstruction, and native vertebral MRI contrast. Results. All VPPs have been technically successful, being well tolerated by patients, improved spinal algal symptomatology, rapid postoperative resumption of patient mobility. There were no major postoperative complications such as material migration into the canal, pulmonary embolism with material, infections, postoperative local haematomas, local or systemic reactions to VertaPlex®. All 21 patients were relieved with improved general condition without major postoperative complications. Clinical follow-up data over a 12-month period, detailed at 1, 3, 6, and 12 months after VPP and assessed with visual analogue scale, the Oswestry Disability Score Index and the Karnofsky Performance Scale have demonstrated, along with technical success, a significantly reduced rate of clinical pain, an improvement in disability and a real increase in quality of life and mobility in patients selected for study. Discussions. PMMA still prevails in choosing as a biomaterial in VPP but is not intrinsically degradable, which is a major barrier to wider applications. In order to eliminate the drawbacks of classical VPPs, new bone cements with biodegradable CPC potential have been generated, with a lower toxic potential than PMMA, and which can be improved by bone-stimulation-enhancing elements. Conclusions. VPP actually increases the quality of life of patients with vertebral spine caused by vertebral metastases and primary vertebral tumors. Biodegradability and biocompatibility, minimal exothermic reactions and insignificant contraction imply that biodegradable and mechanically assembled bone cements without graft rejection will be the future of VPP biomaterials. biomaterials vertebral fractures vertebral metastases vertebral tumors pmma percutaneous vertebroplasty Medicine R Medicine (General) Gabriel IACOB verfasserin aut Alexandru Vlad CIUREA verfasserin aut In Romanian Journal of Medical Practice Amaltea Medical Publishing House, 2019 12(2017), 4, Seite 212-219 (DE-627)634381776 (DE-600)2570962-8 20696108 nnns volume:12 year:2017 number:4 pages:212-219 https://doi.org/10.37897/RJMP.2017.4.7 kostenfrei https://doaj.org/article/f750f5d1257c4c2daaf53f394cbcdbbe kostenfrei https://rjmp.com.ro/articles/2017.4/RJMP_2017_4_Art-07.pdf kostenfrei https://doaj.org/toc/1842-8258 Journal toc kostenfrei https://doaj.org/toc/2069-6108 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 12 2017 4 212-219 |
allfieldsGer |
10.37897/RJMP.2017.4.7 doi (DE-627)DOAJ061155349 (DE-599)DOAJf750f5d1257c4c2daaf53f394cbcdbbe DE-627 ger DE-627 rakwb eng R5-920 Dan Răzvan BENTIA verfasserin aut Biomaterials in percutaneous vertebroplasty 2017 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Aim. The purpose of this study is to reveal the safety and efficacy of biomaterials used in VPP in the treatment of vertebral spinal vertebral patients and primary vertebral tumors. Material and method. The retrospective study (December 2012-December 2015) included 21 patients admitted to the Sanador Hospitals Department of Neurosurgery and Clinical Orthopedics-Traumatology and Osteoarticular TBC "Foişor", Bucharest, with VPP indication. Patients were diagnosed with vertebral spindles produced by vertebral metastases and primary vertebral tumors without compression in the vertebral canal. The diagnosis of these vertebral compressions has been established and confirmed by medical history, medical history, paraclinical investigation studies: column and face colorectal radiographs, native and contrast vertebral CT, 3D bone reconstruction and reconstruction, and native vertebral MRI contrast. Results. All VPPs have been technically successful, being well tolerated by patients, improved spinal algal symptomatology, rapid postoperative resumption of patient mobility. There were no major postoperative complications such as material migration into the canal, pulmonary embolism with material, infections, postoperative local haematomas, local or systemic reactions to VertaPlex®. All 21 patients were relieved with improved general condition without major postoperative complications. Clinical follow-up data over a 12-month period, detailed at 1, 3, 6, and 12 months after VPP and assessed with visual analogue scale, the Oswestry Disability Score Index and the Karnofsky Performance Scale have demonstrated, along with technical success, a significantly reduced rate of clinical pain, an improvement in disability and a real increase in quality of life and mobility in patients selected for study. Discussions. PMMA still prevails in choosing as a biomaterial in VPP but is not intrinsically degradable, which is a major barrier to wider applications. In order to eliminate the drawbacks of classical VPPs, new bone cements with biodegradable CPC potential have been generated, with a lower toxic potential than PMMA, and which can be improved by bone-stimulation-enhancing elements. Conclusions. VPP actually increases the quality of life of patients with vertebral spine caused by vertebral metastases and primary vertebral tumors. Biodegradability and biocompatibility, minimal exothermic reactions and insignificant contraction imply that biodegradable and mechanically assembled bone cements without graft rejection will be the future of VPP biomaterials. biomaterials vertebral fractures vertebral metastases vertebral tumors pmma percutaneous vertebroplasty Medicine R Medicine (General) Gabriel IACOB verfasserin aut Alexandru Vlad CIUREA verfasserin aut In Romanian Journal of Medical Practice Amaltea Medical Publishing House, 2019 12(2017), 4, Seite 212-219 (DE-627)634381776 (DE-600)2570962-8 20696108 nnns volume:12 year:2017 number:4 pages:212-219 https://doi.org/10.37897/RJMP.2017.4.7 kostenfrei https://doaj.org/article/f750f5d1257c4c2daaf53f394cbcdbbe kostenfrei https://rjmp.com.ro/articles/2017.4/RJMP_2017_4_Art-07.pdf kostenfrei https://doaj.org/toc/1842-8258 Journal toc kostenfrei https://doaj.org/toc/2069-6108 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 12 2017 4 212-219 |
allfieldsSound |
10.37897/RJMP.2017.4.7 doi (DE-627)DOAJ061155349 (DE-599)DOAJf750f5d1257c4c2daaf53f394cbcdbbe DE-627 ger DE-627 rakwb eng R5-920 Dan Răzvan BENTIA verfasserin aut Biomaterials in percutaneous vertebroplasty 2017 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Aim. The purpose of this study is to reveal the safety and efficacy of biomaterials used in VPP in the treatment of vertebral spinal vertebral patients and primary vertebral tumors. Material and method. The retrospective study (December 2012-December 2015) included 21 patients admitted to the Sanador Hospitals Department of Neurosurgery and Clinical Orthopedics-Traumatology and Osteoarticular TBC "Foişor", Bucharest, with VPP indication. Patients were diagnosed with vertebral spindles produced by vertebral metastases and primary vertebral tumors without compression in the vertebral canal. The diagnosis of these vertebral compressions has been established and confirmed by medical history, medical history, paraclinical investigation studies: column and face colorectal radiographs, native and contrast vertebral CT, 3D bone reconstruction and reconstruction, and native vertebral MRI contrast. Results. All VPPs have been technically successful, being well tolerated by patients, improved spinal algal symptomatology, rapid postoperative resumption of patient mobility. There were no major postoperative complications such as material migration into the canal, pulmonary embolism with material, infections, postoperative local haematomas, local or systemic reactions to VertaPlex®. All 21 patients were relieved with improved general condition without major postoperative complications. Clinical follow-up data over a 12-month period, detailed at 1, 3, 6, and 12 months after VPP and assessed with visual analogue scale, the Oswestry Disability Score Index and the Karnofsky Performance Scale have demonstrated, along with technical success, a significantly reduced rate of clinical pain, an improvement in disability and a real increase in quality of life and mobility in patients selected for study. Discussions. PMMA still prevails in choosing as a biomaterial in VPP but is not intrinsically degradable, which is a major barrier to wider applications. In order to eliminate the drawbacks of classical VPPs, new bone cements with biodegradable CPC potential have been generated, with a lower toxic potential than PMMA, and which can be improved by bone-stimulation-enhancing elements. Conclusions. VPP actually increases the quality of life of patients with vertebral spine caused by vertebral metastases and primary vertebral tumors. Biodegradability and biocompatibility, minimal exothermic reactions and insignificant contraction imply that biodegradable and mechanically assembled bone cements without graft rejection will be the future of VPP biomaterials. biomaterials vertebral fractures vertebral metastases vertebral tumors pmma percutaneous vertebroplasty Medicine R Medicine (General) Gabriel IACOB verfasserin aut Alexandru Vlad CIUREA verfasserin aut In Romanian Journal of Medical Practice Amaltea Medical Publishing House, 2019 12(2017), 4, Seite 212-219 (DE-627)634381776 (DE-600)2570962-8 20696108 nnns volume:12 year:2017 number:4 pages:212-219 https://doi.org/10.37897/RJMP.2017.4.7 kostenfrei https://doaj.org/article/f750f5d1257c4c2daaf53f394cbcdbbe kostenfrei https://rjmp.com.ro/articles/2017.4/RJMP_2017_4_Art-07.pdf kostenfrei https://doaj.org/toc/1842-8258 Journal toc kostenfrei https://doaj.org/toc/2069-6108 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 12 2017 4 212-219 |
language |
English |
source |
In Romanian Journal of Medical Practice 12(2017), 4, Seite 212-219 volume:12 year:2017 number:4 pages:212-219 |
sourceStr |
In Romanian Journal of Medical Practice 12(2017), 4, Seite 212-219 volume:12 year:2017 number:4 pages:212-219 |
format_phy_str_mv |
Article |
institution |
findex.gbv.de |
topic_facet |
biomaterials vertebral fractures vertebral metastases vertebral tumors pmma percutaneous vertebroplasty Medicine R Medicine (General) |
isfreeaccess_bool |
true |
container_title |
Romanian Journal of Medical Practice |
authorswithroles_txt_mv |
Dan Răzvan BENTIA @@aut@@ Gabriel IACOB @@aut@@ Alexandru Vlad CIUREA @@aut@@ |
publishDateDaySort_date |
2017-01-01T00:00:00Z |
hierarchy_top_id |
634381776 |
id |
DOAJ061155349 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ061155349</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230309010110.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230228s2017 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.37897/RJMP.2017.4.7</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ061155349</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJf750f5d1257c4c2daaf53f394cbcdbbe</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">R5-920</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Dan Răzvan BENTIA</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Biomaterials in percutaneous vertebroplasty</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2017</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Aim. The purpose of this study is to reveal the safety and efficacy of biomaterials used in VPP in the treatment of vertebral spinal vertebral patients and primary vertebral tumors. Material and method. The retrospective study (December 2012-December 2015) included 21 patients admitted to the Sanador Hospitals Department of Neurosurgery and Clinical Orthopedics-Traumatology and Osteoarticular TBC "Foişor", Bucharest, with VPP indication. Patients were diagnosed with vertebral spindles produced by vertebral metastases and primary vertebral tumors without compression in the vertebral canal. The diagnosis of these vertebral compressions has been established and confirmed by medical history, medical history, paraclinical investigation studies: column and face colorectal radiographs, native and contrast vertebral CT, 3D bone reconstruction and reconstruction, and native vertebral MRI contrast. Results. All VPPs have been technically successful, being well tolerated by patients, improved spinal algal symptomatology, rapid postoperative resumption of patient mobility. There were no major postoperative complications such as material migration into the canal, pulmonary embolism with material, infections, postoperative local haematomas, local or systemic reactions to VertaPlex®. All 21 patients were relieved with improved general condition without major postoperative complications. Clinical follow-up data over a 12-month period, detailed at 1, 3, 6, and 12 months after VPP and assessed with visual analogue scale, the Oswestry Disability Score Index and the Karnofsky Performance Scale have demonstrated, along with technical success, a significantly reduced rate of clinical pain, an improvement in disability and a real increase in quality of life and mobility in patients selected for study. Discussions. PMMA still prevails in choosing as a biomaterial in VPP but is not intrinsically degradable, which is a major barrier to wider applications. In order to eliminate the drawbacks of classical VPPs, new bone cements with biodegradable CPC potential have been generated, with a lower toxic potential than PMMA, and which can be improved by bone-stimulation-enhancing elements. Conclusions. VPP actually increases the quality of life of patients with vertebral spine caused by vertebral metastases and primary vertebral tumors. Biodegradability and biocompatibility, minimal exothermic reactions and insignificant contraction imply that biodegradable and mechanically assembled bone cements without graft rejection will be the future of VPP biomaterials.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">biomaterials</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">vertebral fractures</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">vertebral metastases</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">vertebral tumors</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">pmma</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">percutaneous vertebroplasty</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Medicine</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">R</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Medicine (General)</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Gabriel IACOB</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Alexandru Vlad CIUREA</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Romanian Journal of Medical Practice</subfield><subfield code="d">Amaltea Medical Publishing House, 2019</subfield><subfield code="g">12(2017), 4, Seite 212-219</subfield><subfield code="w">(DE-627)634381776</subfield><subfield code="w">(DE-600)2570962-8</subfield><subfield code="x">20696108</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:12</subfield><subfield code="g">year:2017</subfield><subfield code="g">number:4</subfield><subfield code="g">pages:212-219</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.37897/RJMP.2017.4.7</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/f750f5d1257c4c2daaf53f394cbcdbbe</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://rjmp.com.ro/articles/2017.4/RJMP_2017_4_Art-07.pdf</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1842-8258</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2069-6108</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2009</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2011</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2055</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2111</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">12</subfield><subfield code="j">2017</subfield><subfield code="e">4</subfield><subfield code="h">212-219</subfield></datafield></record></collection>
|
callnumber-first |
R - Medicine |
author |
Dan Răzvan BENTIA |
spellingShingle |
Dan Răzvan BENTIA misc R5-920 misc biomaterials misc vertebral fractures misc vertebral metastases misc vertebral tumors misc pmma misc percutaneous vertebroplasty misc Medicine misc R misc Medicine (General) Biomaterials in percutaneous vertebroplasty |
authorStr |
Dan Răzvan BENTIA |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)634381776 |
format |
electronic Article |
delete_txt_mv |
keep |
author_role |
aut aut aut |
collection |
DOAJ |
remote_str |
true |
callnumber-label |
R5-920 |
illustrated |
Not Illustrated |
issn |
20696108 |
topic_title |
R5-920 Biomaterials in percutaneous vertebroplasty biomaterials vertebral fractures vertebral metastases vertebral tumors pmma percutaneous vertebroplasty |
topic |
misc R5-920 misc biomaterials misc vertebral fractures misc vertebral metastases misc vertebral tumors misc pmma misc percutaneous vertebroplasty misc Medicine misc R misc Medicine (General) |
topic_unstemmed |
misc R5-920 misc biomaterials misc vertebral fractures misc vertebral metastases misc vertebral tumors misc pmma misc percutaneous vertebroplasty misc Medicine misc R misc Medicine (General) |
topic_browse |
misc R5-920 misc biomaterials misc vertebral fractures misc vertebral metastases misc vertebral tumors misc pmma misc percutaneous vertebroplasty misc Medicine misc R misc Medicine (General) |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
cr |
hierarchy_parent_title |
Romanian Journal of Medical Practice |
hierarchy_parent_id |
634381776 |
hierarchy_top_title |
Romanian Journal of Medical Practice |
isfreeaccess_txt |
true |
familylinks_str_mv |
(DE-627)634381776 (DE-600)2570962-8 |
title |
Biomaterials in percutaneous vertebroplasty |
ctrlnum |
(DE-627)DOAJ061155349 (DE-599)DOAJf750f5d1257c4c2daaf53f394cbcdbbe |
title_full |
Biomaterials in percutaneous vertebroplasty |
author_sort |
Dan Răzvan BENTIA |
journal |
Romanian Journal of Medical Practice |
journalStr |
Romanian Journal of Medical Practice |
callnumber-first-code |
R |
lang_code |
eng |
isOA_bool |
true |
recordtype |
marc |
publishDateSort |
2017 |
contenttype_str_mv |
txt |
container_start_page |
212 |
author_browse |
Dan Răzvan BENTIA Gabriel IACOB Alexandru Vlad CIUREA |
container_volume |
12 |
class |
R5-920 |
format_se |
Elektronische Aufsätze |
author-letter |
Dan Răzvan BENTIA |
doi_str_mv |
10.37897/RJMP.2017.4.7 |
author2-role |
verfasserin |
title_sort |
biomaterials in percutaneous vertebroplasty |
callnumber |
R5-920 |
title_auth |
Biomaterials in percutaneous vertebroplasty |
abstract |
Aim. The purpose of this study is to reveal the safety and efficacy of biomaterials used in VPP in the treatment of vertebral spinal vertebral patients and primary vertebral tumors. Material and method. The retrospective study (December 2012-December 2015) included 21 patients admitted to the Sanador Hospitals Department of Neurosurgery and Clinical Orthopedics-Traumatology and Osteoarticular TBC "Foişor", Bucharest, with VPP indication. Patients were diagnosed with vertebral spindles produced by vertebral metastases and primary vertebral tumors without compression in the vertebral canal. The diagnosis of these vertebral compressions has been established and confirmed by medical history, medical history, paraclinical investigation studies: column and face colorectal radiographs, native and contrast vertebral CT, 3D bone reconstruction and reconstruction, and native vertebral MRI contrast. Results. All VPPs have been technically successful, being well tolerated by patients, improved spinal algal symptomatology, rapid postoperative resumption of patient mobility. There were no major postoperative complications such as material migration into the canal, pulmonary embolism with material, infections, postoperative local haematomas, local or systemic reactions to VertaPlex®. All 21 patients were relieved with improved general condition without major postoperative complications. Clinical follow-up data over a 12-month period, detailed at 1, 3, 6, and 12 months after VPP and assessed with visual analogue scale, the Oswestry Disability Score Index and the Karnofsky Performance Scale have demonstrated, along with technical success, a significantly reduced rate of clinical pain, an improvement in disability and a real increase in quality of life and mobility in patients selected for study. Discussions. PMMA still prevails in choosing as a biomaterial in VPP but is not intrinsically degradable, which is a major barrier to wider applications. In order to eliminate the drawbacks of classical VPPs, new bone cements with biodegradable CPC potential have been generated, with a lower toxic potential than PMMA, and which can be improved by bone-stimulation-enhancing elements. Conclusions. VPP actually increases the quality of life of patients with vertebral spine caused by vertebral metastases and primary vertebral tumors. Biodegradability and biocompatibility, minimal exothermic reactions and insignificant contraction imply that biodegradable and mechanically assembled bone cements without graft rejection will be the future of VPP biomaterials. |
abstractGer |
Aim. The purpose of this study is to reveal the safety and efficacy of biomaterials used in VPP in the treatment of vertebral spinal vertebral patients and primary vertebral tumors. Material and method. The retrospective study (December 2012-December 2015) included 21 patients admitted to the Sanador Hospitals Department of Neurosurgery and Clinical Orthopedics-Traumatology and Osteoarticular TBC "Foişor", Bucharest, with VPP indication. Patients were diagnosed with vertebral spindles produced by vertebral metastases and primary vertebral tumors without compression in the vertebral canal. The diagnosis of these vertebral compressions has been established and confirmed by medical history, medical history, paraclinical investigation studies: column and face colorectal radiographs, native and contrast vertebral CT, 3D bone reconstruction and reconstruction, and native vertebral MRI contrast. Results. All VPPs have been technically successful, being well tolerated by patients, improved spinal algal symptomatology, rapid postoperative resumption of patient mobility. There were no major postoperative complications such as material migration into the canal, pulmonary embolism with material, infections, postoperative local haematomas, local or systemic reactions to VertaPlex®. All 21 patients were relieved with improved general condition without major postoperative complications. Clinical follow-up data over a 12-month period, detailed at 1, 3, 6, and 12 months after VPP and assessed with visual analogue scale, the Oswestry Disability Score Index and the Karnofsky Performance Scale have demonstrated, along with technical success, a significantly reduced rate of clinical pain, an improvement in disability and a real increase in quality of life and mobility in patients selected for study. Discussions. PMMA still prevails in choosing as a biomaterial in VPP but is not intrinsically degradable, which is a major barrier to wider applications. In order to eliminate the drawbacks of classical VPPs, new bone cements with biodegradable CPC potential have been generated, with a lower toxic potential than PMMA, and which can be improved by bone-stimulation-enhancing elements. Conclusions. VPP actually increases the quality of life of patients with vertebral spine caused by vertebral metastases and primary vertebral tumors. Biodegradability and biocompatibility, minimal exothermic reactions and insignificant contraction imply that biodegradable and mechanically assembled bone cements without graft rejection will be the future of VPP biomaterials. |
abstract_unstemmed |
Aim. The purpose of this study is to reveal the safety and efficacy of biomaterials used in VPP in the treatment of vertebral spinal vertebral patients and primary vertebral tumors. Material and method. The retrospective study (December 2012-December 2015) included 21 patients admitted to the Sanador Hospitals Department of Neurosurgery and Clinical Orthopedics-Traumatology and Osteoarticular TBC "Foişor", Bucharest, with VPP indication. Patients were diagnosed with vertebral spindles produced by vertebral metastases and primary vertebral tumors without compression in the vertebral canal. The diagnosis of these vertebral compressions has been established and confirmed by medical history, medical history, paraclinical investigation studies: column and face colorectal radiographs, native and contrast vertebral CT, 3D bone reconstruction and reconstruction, and native vertebral MRI contrast. Results. All VPPs have been technically successful, being well tolerated by patients, improved spinal algal symptomatology, rapid postoperative resumption of patient mobility. There were no major postoperative complications such as material migration into the canal, pulmonary embolism with material, infections, postoperative local haematomas, local or systemic reactions to VertaPlex®. All 21 patients were relieved with improved general condition without major postoperative complications. Clinical follow-up data over a 12-month period, detailed at 1, 3, 6, and 12 months after VPP and assessed with visual analogue scale, the Oswestry Disability Score Index and the Karnofsky Performance Scale have demonstrated, along with technical success, a significantly reduced rate of clinical pain, an improvement in disability and a real increase in quality of life and mobility in patients selected for study. Discussions. PMMA still prevails in choosing as a biomaterial in VPP but is not intrinsically degradable, which is a major barrier to wider applications. In order to eliminate the drawbacks of classical VPPs, new bone cements with biodegradable CPC potential have been generated, with a lower toxic potential than PMMA, and which can be improved by bone-stimulation-enhancing elements. Conclusions. VPP actually increases the quality of life of patients with vertebral spine caused by vertebral metastases and primary vertebral tumors. Biodegradability and biocompatibility, minimal exothermic reactions and insignificant contraction imply that biodegradable and mechanically assembled bone cements without graft rejection will be the future of VPP biomaterials. |
collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 |
container_issue |
4 |
title_short |
Biomaterials in percutaneous vertebroplasty |
url |
https://doi.org/10.37897/RJMP.2017.4.7 https://doaj.org/article/f750f5d1257c4c2daaf53f394cbcdbbe https://rjmp.com.ro/articles/2017.4/RJMP_2017_4_Art-07.pdf https://doaj.org/toc/1842-8258 https://doaj.org/toc/2069-6108 |
remote_bool |
true |
author2 |
Gabriel IACOB Alexandru Vlad CIUREA |
author2Str |
Gabriel IACOB Alexandru Vlad CIUREA |
ppnlink |
634381776 |
callnumber-subject |
R - General Medicine |
mediatype_str_mv |
c |
isOA_txt |
true |
hochschulschrift_bool |
false |
doi_str |
10.37897/RJMP.2017.4.7 |
callnumber-a |
R5-920 |
up_date |
2024-07-03T19:09:05.298Z |
_version_ |
1803586104525324288 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ061155349</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230309010110.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230228s2017 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.37897/RJMP.2017.4.7</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ061155349</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJf750f5d1257c4c2daaf53f394cbcdbbe</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">R5-920</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Dan Răzvan BENTIA</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Biomaterials in percutaneous vertebroplasty</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2017</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Aim. The purpose of this study is to reveal the safety and efficacy of biomaterials used in VPP in the treatment of vertebral spinal vertebral patients and primary vertebral tumors. Material and method. The retrospective study (December 2012-December 2015) included 21 patients admitted to the Sanador Hospitals Department of Neurosurgery and Clinical Orthopedics-Traumatology and Osteoarticular TBC "Foişor", Bucharest, with VPP indication. Patients were diagnosed with vertebral spindles produced by vertebral metastases and primary vertebral tumors without compression in the vertebral canal. The diagnosis of these vertebral compressions has been established and confirmed by medical history, medical history, paraclinical investigation studies: column and face colorectal radiographs, native and contrast vertebral CT, 3D bone reconstruction and reconstruction, and native vertebral MRI contrast. Results. All VPPs have been technically successful, being well tolerated by patients, improved spinal algal symptomatology, rapid postoperative resumption of patient mobility. There were no major postoperative complications such as material migration into the canal, pulmonary embolism with material, infections, postoperative local haematomas, local or systemic reactions to VertaPlex®. All 21 patients were relieved with improved general condition without major postoperative complications. Clinical follow-up data over a 12-month period, detailed at 1, 3, 6, and 12 months after VPP and assessed with visual analogue scale, the Oswestry Disability Score Index and the Karnofsky Performance Scale have demonstrated, along with technical success, a significantly reduced rate of clinical pain, an improvement in disability and a real increase in quality of life and mobility in patients selected for study. Discussions. PMMA still prevails in choosing as a biomaterial in VPP but is not intrinsically degradable, which is a major barrier to wider applications. In order to eliminate the drawbacks of classical VPPs, new bone cements with biodegradable CPC potential have been generated, with a lower toxic potential than PMMA, and which can be improved by bone-stimulation-enhancing elements. Conclusions. VPP actually increases the quality of life of patients with vertebral spine caused by vertebral metastases and primary vertebral tumors. Biodegradability and biocompatibility, minimal exothermic reactions and insignificant contraction imply that biodegradable and mechanically assembled bone cements without graft rejection will be the future of VPP biomaterials.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">biomaterials</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">vertebral fractures</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">vertebral metastases</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">vertebral tumors</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">pmma</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">percutaneous vertebroplasty</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Medicine</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">R</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Medicine (General)</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Gabriel IACOB</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Alexandru Vlad CIUREA</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Romanian Journal of Medical Practice</subfield><subfield code="d">Amaltea Medical Publishing House, 2019</subfield><subfield code="g">12(2017), 4, Seite 212-219</subfield><subfield code="w">(DE-627)634381776</subfield><subfield code="w">(DE-600)2570962-8</subfield><subfield code="x">20696108</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:12</subfield><subfield code="g">year:2017</subfield><subfield code="g">number:4</subfield><subfield code="g">pages:212-219</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.37897/RJMP.2017.4.7</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/f750f5d1257c4c2daaf53f394cbcdbbe</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://rjmp.com.ro/articles/2017.4/RJMP_2017_4_Art-07.pdf</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1842-8258</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2069-6108</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2009</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2011</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2055</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2111</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">12</subfield><subfield code="j">2017</subfield><subfield code="e">4</subfield><subfield code="h">212-219</subfield></datafield></record></collection>
|
score |
7.4001417 |